NASDAQ:GLUE | Key Financial Ratios | Monte Rosa Therapeutics, Inc.

Complete source-backed ratio history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical Key Financial Ratios

DateCurrent ratioDebt/equityROAROE
2026-06-3010.58-23.31%-33.06%
2026-03-319.54-17.65%-24.91%
2025-12-316.12-8.61%-16.57%
2025-09-306.544.56%8.52%
2025-06-307.166.72%9.02%
2025-03-315.611.56%2.24%
2024-12-312.4-16.57%-32.61%
2024-09-306.03-37.89%-58.11%
2024-06-306.56-37.90%-58.05%
2024-03-314.82-50.72%-88.70%
2023-12-315.07-44.56%-75.51%
2023-09-308.09-52.71%-72.01%
2023-06-3010.9-44.98%-58.65%
2023-03-3111.73-37.73%-47.84%
2022-12-3110.79-31.69%-39.98%
2022-09-3013.55-28.29%-34.75%
2022-06-3020.11-25.66%-31.01%
2022-03-3125.65-24.74%-26.27%
2021-12-3120.96-20.19%-21.28%
2021-09-3029.08-18.27%-19.00%
2021-06-3033.2-15.42%-15.95%
2021-03-3172.35%
2020-12-311.49-72.66%73.63%

Annual Key Financial Ratios

DateCurrent ratioDebt/equityROAROE
2025-12-316.12-8.61%-16.57%
2024-12-312.4-16.57%-32.61%
2023-12-315.07-44.56%-75.51%
2022-12-3110.79-31.69%-39.98%
2021-12-3120.96-20.19%-21.28%
2020-12-311.49-72.66%73.63%